Legalize Psychedelic Medicine


Thanks! Share it with your friends!

You disliked this video. Thanks for the feedback!

Agregado by Siulwon
35 Vistas
Give the gift of healing. Donations are currently being doubled!

In the Multidisciplinary Association for Psychedelic Studies (MAPS)' completed Phase 2 trials with 107 participants, 61% no longer qualified for posttraumatic stress disorder (PTSD) after three sessions of MDMA-assisted psychotherapy two months following treatment. At the 12-month follow-up, 68% no longer had PTSD. All participants had chronic, treatment-resistant PTSD.

MAPS is a non-profit research and educational organization working to develop contexts for careful, beneficial uses of psychedelics and marijuana.

The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to MDMA for the treatment of PTSD. MAPS and the FDA have also reached agreement under the Special Protocol Assessment Process (SPA) for the design of two upcoming Phase 3 trials of MDMA-assisted psychotherapy for patients with severe PTSD.

Visit to learn more.

Your contribution to MAPS helps support the creation of evidence-based treatments for PTSD and other conditions using psychedelic medicines.

*MDMA-Assisted Psychotherapy*
Our highest priority project is funding clinical trials of 3,4-methylenedioxymethamphetamine (MDMA) as a tool to assist psychotherapy for the treatment of posttraumatic stress disorder (PTSD). We are also sponsoring ongoing clinical trials of MDMA-assisted psychotherapy for anxiety associated with life-threatening illness, and MDMA-assisted therapy for social anxiety in autistic adults.

*LSD-Assisted Psychotherapy*
MAPS has completed the first double-blind, placebo-controlled study of the therapeutic use of LSD in human beings since the early 1970s.

*Ibogaine Therapy for Drug Addiction*
We are studying the long-term effects of ibogaine treatment on patients presently undergoing therapy at independent ibogaine treatment centers in Mexico and New Zealand.

*Ayahuasca-Assisted Treatment*
MAPS supports research into the safety and effectiveness of ayahuasca-assisted treatment for drug addiction and PTSD. We also support conferences, meetings, and publications about the scientific, therapeutic, sustainable, and spiritual uses of ayahuasca.

*Medical Marijuana*
MAPS has received regulatory approval to conduct a study of smoked marijuana for symptoms of posttraumatic stress disorder (PTSD) in veterans of war.

Learn more about MAPS and support psychedelic research:


*Video Credits*
—Editor: Andrew O'Keefe (
—Editor: Renee Rosky
—Music: Erothyme - Relief Remains (
—Additional footage: ENDPAIN (


Support psychedelic science:
Otras Drogas Other languages Maps Social

Deja tu comentario

Inicia Sesión o Registrate para dejar comentarios.


Anímate! Se el primero en comentar este video